Fludarabine and Cytarabine Versus High-dose Cytarabine in Consolidation Treatment of Core-bing Factor Acute Myeloid Leukemia: A Prospective, Multicenter, Randomized Study
Latest Information Update: 04 Oct 2024
At a glance
- Drugs Cytarabine (Primary) ; Fludarabine (Primary)
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- 30 Sep 2024 Status changed from recruiting to completed.
- 05 May 2022 Planned End Date changed from 1 Jul 2020 to 1 Jul 2024.
- 12 Oct 2016 New trial record